D.E. Shaw & Co
CTSO icon

D.E. Shaw & Co’s Cytosorbents Corp CTSO Stock Holding History

D.E. Shaw & Co’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50,767
Closed -$195K – 3977
2019
Q4 		$195K Buy
+50,767
New +$221K ﹤0.01% 3806
2019
Q3 		– Sell
-24,860
Closed -$164K – 3840
2019
Q2 		$164K Buy
+24,860
New +$171K ﹤0.01% 3500
2019
Q1 		– Sell
-21,583
Closed -$174K – 3646
2018
Q4 		$174K Buy
+21,583
New +$214K ﹤0.01% 3572
2018
Q3 		– Sell
-18,350
Closed -$209K – 3760
2018
Q2 		$209K Buy
+18,350
New +$174K ﹤0.01% 3541

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

D.E. Shaw & Co's CTSO Position: Q1 2020 in Review

D.E. Shaw & Co sold out of Cytosorbents Corp (CTSO) in Q1 2020, closing a stake of 50,767 shares — an estimated $195K sold.

D.E. Shaw & Co first reported a position in CTSO in Q2 2018 and held it in 4 quarters. The position peaked at $209K in Q2 2018. 82 funds tracked by Wall St. Rank hold CTSO as of Q1 2020.

  • D.E. Shaw & Co reported no remaining Cytosorbents Corp position as of Q1 2020 after selling out during the quarter.
  • D.E. Shaw & Co sold 50,767 Cytosorbents Corp shares in Q1 2020, an estimated $195K.
  • D.E. Shaw & Co first reported a position in Cytosorbents Corp in Q2 2018 and held it in 4 quarters.
  • D.E. Shaw & Co's Cytosorbents Corp position peaked at $209K in Q2 2018.
  • 82 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2020.

Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.